Amelioration of graft versus host disease with anti-ICAM-1 therapy

Journal of Surgical Research

Volumn 80, Issue 2, 1998, Pages 280-286

  Poritz, Lisa S ^a   Page, Michael J ^a   Tilberg, Anna F ^a   Koltun, Walter A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Graft versus host disease; Intercellular adhesion molecule 1; Intestinal inflammation; Small bowel transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG POTENTIATION; GRAFT VERSUS HOST REACTION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSPLANTATION; LEUKOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN EXAMINATION; SURVIVAL TIME; WEIGHT REDUCTION;

EID: 0032434774     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5422     Document Type: Article

References (50)

1. Pirenne J., Benedetti E., Dunn D. L. Graft versus host response: Clinical and biological relevance after transplantation of solid organs. Transplant. Rev. 10:1997;46.
2. Albelda S. M., Buck C. A. Integrins and other cell adhesion molecules. FASEB J. 4:1990;2868.
3. Kawasaki K., Yaoita E., Yamamoto T., Tamatani T., Miyasaka M., Kihara I. Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J. Immunol. 150:1993;1074.
4. Kavanaugh A. F., Davis L. S., Jain R. I., Nichols L. A., Norris S. N., Lipsky P. E. A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD45) monoclonal antibody in early rheumatoid arthritis. J. Rheumatol. 23:1996;1338.
5. Schuermann G. M., Aber-Bishop A. E., Facer P., Lee J. C., Rampton D. S., Dore C. J., Polak J. M. Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin. Exp. Immunol. 94:1993;341.
6. Wong P. Y. K., Yue G., Yon K., Miyasaka M., Lane C. L., Manning A. M., Anderson D. C., Sun F. F. Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease. J. Pharmacol. Exp. Ther. 274:1995;475.
7. Poritz, L. S. Olt, G. Ruggiero, F. M. Colony, P. Tilberg, A. F. Koltun, W. A. Increased LFA-1 expression in the intestines of rats with GVHD after small bowel transplantation, Dig. Dis. Sci.
8. Nakamura S., Ohtani H., Watanabe Y., Fukushima K., Matsumoto T., Kitano A., Kobayashi K., Nagura H. In situ expression of the cell adhesion molecules in inflammatory bowel disease, evidence of immunologic activation of vascular endothelial cells. Lab. Invest. 69:1993;77.
9. Poritz, L. S. Page, M. J. Tilberg, A. F. Olt, G. Ruggiero, F. M. Koltun, W. A. Monoclonal antibody to lymphocyte function associated antigen-1 improves graft versus host disease, Dis. Colon Rectum.
10. Koltun W. A., Bloomer M. M., Kauffman G. L., Colony P. C. Intestinal graft versus host disease (GVHD) is most severe in the distal small bowel. Gastroenterology. 106:1994;A713.
11. Koltun W. A., Bloomer M. M., Colony P. C., Ruggiero F., Kauffman G. L. Graft versus host disease after small bowel transplantation is associated with host colonic injury. Dig. Dis. Sci. 40:1995;1925.
12. Schraut W. H., Lee K. K. W., Dawson P. J., Hurst R. D. Graft-versus-host disease induced by small bowel allografts, clinical course and pathology. Transplantation. 41:1986;286.
13. Grant D., Zhong R., Gunn H., Duff J., Garcia B., Keown P., Wijsman J., Stiller C. Graft-versus-host disease associated with intestinal transplantation in the rat, host immune function and general histology. Transplantation. 48:1989;545.
14. Monchik G. J., Russell P. S. Transplantation of small bowel in the rat: Technical and immunological considerations. Surgery. 70:1971;693.
15. Tamatani T., Kotani M., Miyasaka M. Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit specific monoclonal antibodies. Eur. J. Immunol. 21:1991;627.
16. Tamatani T., Miyasaka M. Indentification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int. Immunol. 2:1990;165.
17. Nakao Y., Mackinnon S. E., Hertl M. C., Miyasaka M., Hunter D. A., Mohanakumar T. Monoclonal antibodies against ICAM-1 and LFA-1 prolong nerve allograft survival. Muscle Nerve. 18:1995;93.
18. Chowdhury N. C., Jin M. X., Oluwole S. F. Prevention of graft-versus-host disease in rat small bowel transplantation by recipient pretreatment with UV-B-modulated bone marrow cells. Transplantation. 55:1993;1229.
19. Saat R. E., deBruin R. W. F., Marquet R. L., Jeekel J. Total orthotopic allogeneic small bowel transplantation in rats. Attempts to ameliorate the graft-versus-host disease by irradiation and transfusions of the donor. Transplantation. 47:1989;451.
20. Koltun W. A., Bloomer M. M., Colony P., Kauffman G. L. Increased intestinal permeability in rats with graft versus host disease. Gut. 39:1996;291.
21. Sanderson I. R., Boulton P., Menzies I., Walker-Smith J. A. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut. 28:1987;1073.
22. Rocklin R. D., Pohl C. A. Determination of carbohydrates by anion exchange chromatography with pulsed amperometeric detection. J. Liquid Chromatogr. 6:1983;1577.
23. Springer T. S. Adhesion receptors of the immune system. Nature. 346:1990;425.
24. Harvey J. E., Hogg N., Landis R. C. LFA-1 and the ICAMs. Lymphocyte Adhesion Molecules. 1993;Landes, Austin. p. 26-53.
25. Nielsen O. H., Langholz E., Hendel J., Brynskov J. Circulating soluble intercellular adhesion molecule-1 (sICAM-1) in active inflammatory bowel disease. Dig. Dis. Sci. 39:1994;1918.
26. Maeda Y., Chihara J., Fusanari H., Miyatake J., Tatsumi Y., Urase F., Irimajiri K., Nakajima S., Horiuchi A. Elevated levels of soluble ICAM-1 in serum of patients with acute myeloid leukemia undergoing bone marrow transplantation. Am. J. Hematol. 52:1996;227.
27. Reid S. D., Uff C. R., Wood R. F. M., Pockley A. G. Increased ICAM-1 and LFA-1 expression with developing rejection following rat small bowel transplantation. Transplant. Proc. 26:1994;1519.
28. Aoki S., Imai K., Yachi A. Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand. J. Immunol. 38:1993;485.
29. Yamataka T., Kobayashi H., Yagita H., Okumura K., Tamatani T., Miyasaka M. The effect of anti-ICAM-1 monoclonal antibody treatment on the transplantation of the small bowel in rats. J. Pediatr. Surg. 28:1993;1451.
30. Kawabe A., Suzuki H., Kimura T., Harada Y., Tamatani T., Miyasaka M. Immunosuppressive effects of monoclonal antibodies against adhesion molecules in rat pancreas allografts. Transplant. Proc. 26:1994;1937.
31. Harihara Y., Sakamoto H., Sanjo K., Otsubo O., Watanabe G., Idezuki Y. Prolongation of hepatic allograft survival with antibodies to ICAM-1 and LFA-1. Transplant. Proc. 26:1994;2258.
32. Kawabe A., Kimura T., Suzuki H., Suzuki K., Haraada Y. Anti-adhesion (anti-ICAM-1 and anti-LFA-1) therapy in a rat pancreas transplantation model. Transplant. Proc. 28:1996;1808.
33. Zeng Y., Gage A., Montag A., Rothlein R., Thistlewaite J. R., Bluestone J. A. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation. 58:1994;681.
34. Isobe M., Yagita H., Okumura K., Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science. 255:1992;1125.
35. van Dijken P. J., Ghayur T., Mauch P., Down J., Burakoff S. J., Ferrara J. L. M. Evidence that anti-LFA-1in vivo. Transplantation. 49:1990;882.
36. Fischer A., Friedrich W., Fasth A., Blanche S., LeDeist F., Girault D., Veber F., Vossen J., Lopez M., Griscelli C., Hirn M. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: A European group for immunodeficiency/European group for bone marrow transplantation report. Blood. 77:1991;249.
37. Haug C. E., Colvin R. B., Delmonico F. L., Aushincloss H., Tolkoff-Rubin N., Preffer F. I., Rothlein R., Norris S., Scharschmidt L., Cosmi A. B. A phase I trial of immunosuppression with anti-ICAM-1 (CD45) mAb in renal allograft recipients. Transplantation. 55:1993;766.
38. Schiltz P. M., Giorno R. C., Claman H. N. Increased ICAM-1 expression in the early stages of murine chronic graft-versus-host disease. Clin. Immunol. Immunopathol. 71:1994;136.
39. Poritz L. S., Tilberg A. F., Koltun W. A. Decreased expression of LFA-1 on peripheral blood lymphocytes in GVHD. J. Surg. Res. 69:1997;316.
40. Lee K. K. W., Schraut W. H. In vitro. J. Surg. Res. 38:1985;364.
41. Kirkman R. L., Lear P. A., Madara J. L., Tilney N. L. Small intestine transplantation in the rat-immunology and function. Surgery. 96:1984;280.
42. Murase N., Demetris A. J., Woo J., Tanabe M., Furuya T., Todo S., Starzl T. E. Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-brown Norway rat intestinal transplantation under FK506. Transplantation. 55:1993;1.
43. Eigenbrodt M. L., Eigenbrodt E. H., Theile D. L. Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease. Am. J. Pathol. 137:1990;1065.
44. Sartor R. B., Murphy M. E. Cytokines in inflammatory bowel disease. Regul. Peptide Lett. 4:1993;65.
45. Gallucci B. B., Epstein R., Sale G. E., Shulman H. M., McDonald G. B., Thomas E. D. The fine structure of human rectal epithelium in acute graft-versus-host disease. Am. J. Surg. Pathol. 6:1982;293.
46. Roy J., Platt J. L., Weisdorf D. J. The immunopathology of upper gastrointestinal acute graft-versus-host disease, lymphoid cells and endothelial adhesion molecules. Transplantation. 55:1993;572.
47. Bennett C. F., Kornbrust D., Henry S., Stecker K., Howard R., Cooper S., Dutson S., Hall W., Jacoby J. I. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J. Pharmacol. Exp Ther. 280:1997;988.
48. Yacyshyn B., Woloschik B., Yacyshyn D., Martini D., Doan K., Tami J., Bennet F., Kisner D., Shanahan W. Efficacy and Safety of ISIS 2302 (ICAM-1 antisense oligonucleotide) treatment of steroid-dependent Crohn's disease. Gastroenterology. 112:1997;A1123.
49. Poritz L. S., Page M. J., Tilberg A. F., Koltun W. A. Tumor necrosis factor binding protein (TNFbp) treatment improves graft versus host disease (GVHD) after small bowel transplantation. Surg. Forum. 48:1997;495.
50. Pirenne J., Silva M. D., Degiovanni G., Jacquet N., Dunn D. L. Relevance of tumor necrosis factor to graft-versus-host disease after small bowel transplantation. Transplant. Int. 6:1993;258.